Patent · US Active

Protease inhibitors

US12378209B2 · kind B2 · utility

0Cited by

7References

1Claims

0Family size

Assignee

MEDIVIR AB · SE

Inventors

Lourdes Salvador ODEN · Huddinge, SE
Magnus Nilsson · Mölndal, SE
Pia Kahnberg · Huddinge, SE
Bertil Samuelsson · Huddinge, SE
Urszula Grabowska · Huddinge, SE

Key dates

Filing date	Apr 25, 2022
Grant date	Aug 5, 2025
Priority date	—
Expiry date	May 4, 2044

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of the formula II:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.